Panbela Therapeutics (PBLA) Stock Chart & Stock Price History $0.01 +0.00 (+0.91%) As of 10/3/2025 01:05 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Stock Price Performance The Panbela Therapeutics (PBLA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 96.83%, with a year-to-date return of -97.08%. In the past month, the stock has decreased 92.60%, reflecting recent market activity. As of the latest close, Panbela Therapeutics traded at $0.01 with a market cap of $54 thousand and volume of 814 shares. Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-77.80%1 Month PerformanceN/A3 Month Performance-93.06%Year-To-Date Performance-97.08%1 Year Performance-96.83% PBLA Stock Chart for Saturday, October, 4, 2025 PBLA Chart by TradingView Panbela Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$0.01$0.01+0.91%$0.01$0.01814 shs$54,000.0010/02/2025$0.01$0.01-0.90%$0.15$0.0136,100 shs$53,000.0010/01/2025$0.05$0.01-77.80%$0.01$0.013,509 shs$54,000.0009/30/2025$0.05$0.05$0.05$0.0524 shs$243,000.0009/29/2025$0.05$0.05$0.05$0.0516 shs$243,000.0009/26/2025$0.05$0.05$0.05$0.05156 shs$243,000.0009/25/2025$0.05$0.05$0.05$0.05156 shs$243,000.0009/24/2025$0.05$0.05$0.05$0.05144 shs$243,000.0009/23/2025$0.05$0.05-0.20%$0.05$0.05144 shs$243,000.0009/22/2025$0.05$0.05$0.05$0.052,750 shs$243,000.00 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$0.05$0.05$0.05$0.051,819 shs$243,000.0009/18/2025$0.05$0.05+3.73%$0.05$0.051,819 shs$243,000.0009/17/2025$0.05$0.05-3.40%$0.05$0.05647 shs$234,000.0009/16/2025$0.05$0.05$0.05$0.053,005 shs$243,000.0009/09/2025$0.05$0.05$0.05$0.054,094 shs$243,000.0009/08/2025$0.15$0.05-66.67%$0.05$0.054,094 shs$243,000.0009/03/2025$0.15$0.15$0.15$0.01349 shs$728,000.00 Related Companies Petros Pharmaceuticals Stock Chart Biophytis Stock Chart Hepion Pharmaceuticals Stock Chart Bio-Path Stock Chart Orgenesis Stock Chart Bon Natural Life Stock Chart Vincerx Pharma Stock Chart NuCana Stock Chart Virpax Pharmaceuticals Stock Chart Smart for Life Stock Chart Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBLA) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
